Professional and Personal Toxic Exposure in Systemic Sclerosis : Type, Intensity and Probability of Exposition
VISSEXPOSITION
1 other identifier
observational
226
1 country
1
Brief Summary
Systemic Sclerosis (SSc) is an inflammatory chronic disease that can lead to structural damage and handicap. The SSc physiopathology is multifactorial, including genetic and environmental risk factors. The identification of environmental factors implication is crucial to understand the SSc mechanism, and improves the diagnosis and the treatment of the disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2018
CompletedFirst Posted
Study publicly available on registry
June 1, 2018
CompletedStudy Start
First participant enrolled
June 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2019
CompletedSeptember 11, 2019
September 1, 2019
1.1 years
May 18, 2018
September 10, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analyse type, intensity and probability of toxic substances exposition in Systemic Sclerosis patients through an auto-questionnaire and integration of these data in a computer matrix
At baseline (day 0)
Study Arms (1)
Systemic Sclerosis patient
patients affected by SSc according to EULAR 2013 criteria
Interventions
Eligibility Criteria
Patients affected by SSc according to EULAR 2013 criteria.
You may qualify if:
- Patients aged over 18 years old
- Speaking and understanding French language
- Being informed about the study and having given his consent
- Affected by SSc according to EULAR 2013 criteria
You may not qualify if:
- Patient under tutorship
- Patient who refuse to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux - service de rhumatologie
Bordeaux, France
Related Publications (1)
Galli G, De Pous-Gerardin C, Hanguehard R, Berthy F, Le Moal C, Lourde C, Barnetche T, Skopinski S, Contin-Bordes C, Delva F, Carles C, Truchetet ME. Occupational quantitative exposure to crystalline silica, solvents and pesticides and risk of clinical forms of systemic sclerosis. Rheumatology (Oxford). 2024 Dec 1;63(12):3397-3406. doi: 10.1093/rheumatology/kead602.
PMID: 37963059DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Elise TRUCHETET, MD, PhD
University Hospital, Bordeaux
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2018
First Posted
June 1, 2018
Study Start
June 4, 2018
Primary Completion
June 27, 2019
Study Completion
June 27, 2019
Last Updated
September 11, 2019
Record last verified: 2019-09